loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: Arcapta neohaler (TN)

    Menu

    Arcapta neohaler (TN)

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 203,185Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 207930 / DOSAGE - POWDER;INHALATION - 15.6MCG/INH;27.5MCG/INH

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    GLYCOPYRROLATE(UNII: V92SO9WP2I)
    (GLYCOPYRRONIUM - UNII:A14FB57V1D)     		GLYCOPYRROLATE15.6ug
    INDACATEROL MALEATE(UNII: 2JEC1ITX7R)
    (INDACATEROL - UNII:8OR09251MQ)     		INDACATEROL27.5ug

    Inactive Ingredients

    Ingredient Name
    Novartis Pharmaceuticals Corporation
    Sunovion Pharmaceuticals Inc.
    LACTOSE MONOHYDRATE(EWQ57Q8I5X)
    MAGNESIUM STEARATE(70097M6I30)